ALUROTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ALURW

ALLURION TECHNOLOGIES, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 15, 2026

$0.47+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $6.34M
P/E (TTM): –
Dividend yield: –

ALLURION TECHNOLOGIES, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Revenue	15	32	53	64
Cost of Revenue	5.66	11	12	13
Gross Profit	9.57	22	41	51
Research & Development	7.57	17	28	17
Selling, General & Admin	32	54	93	66
Selling & Marketing	11	26	47	50
General & Administrative	21	28	46	15
Advertising Expenses	1.50	4.90	11	16
Operating Expenses	40	72	121	83
Operating Income	-30	-50	-79	-32
Interest Expense	0	2.26	11	4.43
Other Non-Operating Income	1.48	44	-3.48	-5.59
Merger & Restructuring Charges	–	3.90	1.00	–
Pretax Income	-29	-6.48	-83	-38
Income Tax Expense	0.07	0.72	0.26	0.14
Net Income incl. Noncontrolling Interests	-29	-7.20	-83	-38
Net Income	-29	-7.20	-83	-38
Net Income to Common	–	-7.20	-85	-41
EPS (Basic)(per share)	-3.81	-3.20	-16.97	-10.79
EPS (Diluted)(per share)	-3.81	-3.20	-16.97	-10.79
Shares Outstanding (Basic, Weighted)(shares)	7.54	2.25	4.98	3.77
Shares Outstanding (Diluted, Weighted)(shares)	7.54	2.25	4.98	3.77
EBITDA	-29	-49	-78	-31

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: 52.7%
Operating margin: -211.2%
Net margin: -264.7%
Return on equity, FY2025: 37.1%

Financial strength

Current ratio: 0.30
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 13.6%

Valuation

P/E ratio: –
Price to sales: 0.50
Price to book: –
Dividend yield: –